Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil effectively treats hair loss, with better results in women.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Finasteride may help some women with hair loss, but better options exist.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Stress worsens Tourette symptoms by increasing allopregnanolone levels.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Ketoconazole shampoo treats dandruff and reduces hair greasiness.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

COVID-19 may harm male fertility and damage the reproductive system.

Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Korean patients with PCOS often have skin problems like acne and excess hair, with different symptoms based on their specific PCOS type.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Finasteride side effects in young men may be linked to specific gene variations.